Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
51,414,850
-
Share change
-
+827,842
-
Total reported value
-
$3,496,341,436
-
Put/Call ratio
-
39%
-
Price per share
-
$68.00
-
Number of holders
-
245
-
Value change
-
+$19,380,879
-
Number of buys
-
115
-
Number of sells
-
128
Institutional Holders of CLOVIS ONCOLOGY INC - COM (CLVSQ) as of Q4 2017
As of 31 Dec 2017,
CLOVIS ONCOLOGY INC - COM (CLVSQ) was held by
245 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
51,414,850 shares.
The largest 10 holders included
Vanguard Group Inc, BlackRock Inc., Palo Alto Investors, LLC, PointState Capital LP, FRANKLIN RESOURCES INC, FMR LLC, ORBIMED ADVISORS LLC, STATE STREET CORP, Carmignac Gestion, and Redmile Group, LLC.
This page lists
245
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.